Dr Antoneta Granic
Dr Karen Suetterlin
Professor Avan Sayer
| Hallmarks of ageing in human skeletal muscle and implications for understanding the pathophysiology of sarcopenia in women and men | 2023 |
|
Dr Karen Suetterlin
| Excitability properties of mouse and human skeletal muscle fibres compared by muscle velocity recovery cycles | 2022 |
|
Dr Karen Suetterlin
| The long exercise test as a functional marker of periodic paralysis | 2022 |
|
Dr Karen Suetterlin
Emma Matthews
| Translating genetic and functional data into clinical practice: a series of 223 families with myotonia | 2022 |
|
Dr Karen Suetterlin
Professor Avan Sayer
Professor Michael Hanna
| Ageing Contributes to Phenotype Transition in a Mouse Model of Periodic Paralysis | 2021 |
|
Dr Karen Suetterlin
Professor Michael Hanna
Emma Matthews
| Andersen-Tawil Syndrome Presenting with Complete Heart Block | 2021 |
|
Dr Karen Suetterlin
Professor Michael Hanna
| Annual renal ultrasound may prevent acute presentation with acetazolamide-associated urolithiasis | 2021 |
|
Dr Karen Suetterlin
Professor Michael Hanna
| Mexiletine (NaMuscla) for the treatment of myotonia in non-dystrophic myotonic disorders | 2020 |
|
Dr Karen Suetterlin
Professor Michael Hanna
| Muscle channelopathies | 2016 |
|
Dr Karen Suetterlin
| Long-term Safety and Efficacy of Mexiletine for Patients with Skeletal Muscle Channelopathies. | 2015 |
|
Dr Karen Suetterlin
| Diagnosis and management of headache | 2014 |
|
Dr Karen Suetterlin
Professor Michael Hanna
| Muscle channelopathies: recent advances in genetics, pathophysiology and therapy. | 2014 |
|
Dr Karen Suetterlin
Professor Avan Sayer
| Proprioception: where are we now? A commentary on clinical assessment, changes across the life course, functional implications and future intervention. | 2014 |
|
Dr Karen Suetterlin
| When is “idiopathic intracranial hypertension” no longer idiopathic? | 2014 |
|
